Live Quote · OTCNICXFHealthcare · Biotechnology

Nicox S.A.

$0.30▲ 0.00%(+$0.00)

TickerSpark Score

67/100

▌ Solid

70

Valuation

35

Profitability

100

Growth

68

Health

60

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NICXF research report →

52-Week Range30% of range

Low

$0.24

Current

$0.30

High

$0.44

Company Overviewwww.nicox.com

About the company

Nicox S. A. is an international ophthalmic pharmaceutical company, headquartered in Valbonne, France, and established in 1996.

CEO: Gavin Spencer
IPO: 2010
Employees: 28
HQ: Biot, FR

Price Chart

+20.00% · this period

Valuation

Market Cap: $28.04M
P/E: -13.92
P/S: 1.82
P/B: 5.58
EV/EBITDA: 1.42
Div Yield: 0.00%

Profitability

Gross Margin: 38.99%
Op Margin: -81.33%
Net Margin: -14.39%
ROE: -51.16%
ROIC: -163.75%

Growth & Income

Revenue: $16.76M · 113.32%
Net Income: $-2,412,095.7 · 89.23%
EPS: $-0.03 · 93.40%
Op Income: $3.16M
FCF YoY: 0.00%

Performance & Tape

52W High: $0.44
52W Low: $0.24
50D MA: $0.30
200D MA: $0.29
Beta: 0.52
Avg Volume: 92.308

Get TickerSpark's AI analysis on NICXF

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · NICXF